The 9 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 64.00, with a high estimate of 75.00 and a low estimate of 53.00. The median estimate represents a +4.44% increase from the last price of 61.28.
The current consensus among 13 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.91
Reporting Date Jan 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.